Reversal of glucocorticoid resistance by AKT inhibition in T-ALL
收藏官方服务：
资源简介：
Reversal of glucocorticoid resistance by AKT inhibition in T-ALL
应用场景：
创建时间：
2013-05-30
相关数据集
Table_1_Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells.xlsx
Poly (ADP-ribose) polymerase inhibitor (PARPi) resistance is a new challenge for antitumor therapy. The purpose of this study was to investigate the reversal effects of chidamide on fluzoparib resista
NIAID Data Ecosystem70
Additional file 1: of Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
Table S1. CI values for SGC7901, SGC7901/ADR and SGC7901/VCR. CI was calculated by CompuSyn, which is based on the model created by Chou and Talalay. CI 1 represent synergism, additive effect and anta
Figshare2018-11-10 更新50
Transcriptomic analyssis following EHMT1/2 inhibition. Transcriptomic analyssis following EHMT1/2 inhibition
RNA was isolated from PEO1 olaparib resistant (PEO1-OR) cells grown in complete growth media or PEO1-OR clone 4 cells grown in complete growth media with 500 nanomolar of UNC0642 for 72 hrs. RNA-seque
NIAID Data Ecosystem40
Gene expression signature of primary T-ALL cells treated with the PI3K inhibitor AS605240. Homo sapiens
The PI3K pathway is frequently hyperactivated in primary T-cell acute lymphoblastic leukemia (T-ALL) cells. Activation of the PI3K pathway has been suggested as one mechanism of glucocorticoid resista
NIAID Data Ecosystem70
Supplementary Table S3 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
Supplementary Table S3
Figshare2023-01-03 更新50
